Numerous technological advancements have been integrated into proteomics array technologies. Enhanced surface chemistries combined with enlarged content menus are allowing manufacturers to develop ...

The proteomics market is experiencing strong growth as demand rises for advanced tools that analyze protein structure, function, and interactions. Proteomics plays a critical role in understanding ...

Biognosys’ proprietary P2 Plasma Enrichment System enables plasma proteome profiling with unprecedented depth and throughput, both as contract research and in-house via licensing By offering the ...

According to MarketsandMarkets™, the Proteomics Market is projected to grow from about USD 36.32 billion in 2025 to USD 65.78 billion by 2030, at a CAGR of 12.6%.

Industry leaders outline how advances in MS, affinity platforms, sample preparation, AI-driven analysis, and data standardization are transforming proteomics. These innovations are enabling deeper and ...

Advancements in spatial proteomics enable detailed tissue mapping, linking protein localization to disease mechanisms and ...

New nanoElute 2 features nano-LC advances, supports automated single cell sample preparation from label-free ProteoCHIP on CellenONE platform MetaboScape® 2023 advances fluxomics applications and ion ...

MAASTRICHT, Netherlands--(BUSINESS WIRE)--At the International Mass Spectrometry Conference (IMSC 2022), Bruker Corporation (Nasdaq: BRKR) today announced the launch of the new nanoElute® 2 nano-LC, ...

SCHLIEREN, Switzerland and BILLERICA, Mass., Jan. 04, 2023 (GLOBE NEWSWIRE) -- Biognosys AG and Bruker Corporation (Nasdaq: BRKR) today announced a strategic partnership, in which Bruker has made a ...

The 21st century has witnessed remarkable advances in molecular biology. Not only are these advances transforming our understanding of life’s most fundamental processes, but they are also starting to ...